Home
Conditions
Skin Neoplasms

Clinical trial condition

Skin Neoplasms

Explore clinical trials studying Skin Neoplasms. Study availability and eligibility vary by location and protocol.

2,111 public trials 360 recruiting studies

Refine in advanced search Browse all conditions

Skin Neoplasms trial results

Completed

Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02)

NCT04305054

Conditions: Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms, +11 more
Locations: The Angeles Clinic and Research Institute ( Site 2009) Los Angeles, California, United States

UCLA Hematology & Oncology ( Site 2004) Los Angeles, California, United States

Providence Saint John's Health Center ( Site 2010) Santa Monica, California, United States

University of Colorado, Anschutz Cancer Pavilion ( Site 2012) Aurora, Colorado, United States

View all 60 locations

View Trial Details

Completed

A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)

NCT00600496

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +40 more
Locations: Research Site Detroit, Michigan, United States

Research Site Philadelphia, Pennsylvania, United States

Research Site Nashville, Tennessee, United States

Research Site Houston, Texas, United States

View Trial Details

Completed

Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma

NCT03336606

Conditions: Carcinoma, Carcinoma, Squamous Cell, Cell Cancer, Squamous, +18 more
Locations: Providence Portland Medical Center Portland, Oregon, United States

View Trial Details

Completed

Expression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint Inhibitors

NCT04253080

Conditions: Cutaneous Melanoma, Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, +11 more
Locations: Dermatology department Paris, Île-de-France Region, France

View Trial Details

Completed

Dose Escalation Study With Expansion to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of CCT3833

NCT02437227

Conditions: Cancer, Melanoma, Neoplasms, +10 more
Locations: Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom

Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom

View Trial Details

Completed

A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy

NCT01624220

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +60 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response

NCT04146064

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +26 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Completed

QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.

NCT03552718

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +45 more
Locations: Chan Soon-Shiong Institute for Medicine El Segundo, California, United States

View Trial Details

Completed

Family History App in Personalized Medicine

NCT04726319

Conditions: Adnexal Diseases, Arterial Occlusive Diseases, Arteriosclerosis, +55 more
Locations: Mount Sinai Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Melanoma

NCT06463509

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Department of Dermatology, University Hospital Zurich Zurich, Canton of Zurich, Switzerland

View Trial Details

Skin Neoplasms

Skin Neoplasms trial results

Related conditions